M032
Showing 1 - 25 of 1,259
Glioblastoma Multiforme, Anaplastic Astrocytoma, Gliosarcoma Trial in Birmingham (M032, Pembrolizumab)
Recruiting
- Glioblastoma Multiforme
- +2 more
- M032
- Pembrolizumab
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Jan 30, 2023
Recurrent Glioblastoma Multiforme, Progressive Glioblastoma Multiforme, Anaplastic Astrocytoma or Gliosarcoma Trial in
Active, not recruiting
- Recurrent Glioblastoma Multiforme
- +2 more
- M032 (NSC 733972)
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Jan 26, 2022
Healthy Subject Trial in North York (ALS-4, Placebo)
Completed
- Healthy Subject
- ALS-4
- Placebo
-
North York, Ontario, CanadaBioPharma Services Inc.
Apr 19, 2022
Ovarian Carcinoma Trial in Israel, United States (Denosumab, Salpingo-Oophorectomy)
Terminated
- Ovarian Carcinoma
- Denosumab
- Salpingo-Oophorectomy
-
Boston, Massachusetts
- +5 more
May 23, 2022
NonSegmental Vitiligo Trial in Canada, United States (INCB054707, Placebo)
Active, not recruiting
- NonSegmental Vitiligo
- INCB054707
- Placebo
-
Hoover, Alabama
- +30 more
Nov 14, 2022
Recurrent Ovarian Cancer, Recurrent Fallopian Tube Carcinoma, Recurrent Primary Peritoneal Carcinoma Trial in Worldwide
Active, not recruiting
- Recurrent Ovarian Cancer
- +2 more
- Relacorilant, 100mg QD
- +3 more
-
Birmingham, Alabama
- +20 more
Jun 27, 2022
Brain Tumors Trial in Canada, United States (temozolomide, thiotepa, carboplatin, 13-cis-retinoic acid)
Completed
- Brain Tumors
- temozolomide, thiotepa, carboplatin, 13-cis-retinoic acid
-
Phoenix, Arizona
- +16 more
Jun 17, 2021
SARS-CoV-2 Infection, COVID-19 Trial in United Kingdom (SARS-CoV-2 rS/Matrix M1-Adjuvant, Placebo, Licensed seasonal influenza
Active, not recruiting
- SARS-CoV-2 Infection
- COVID-19
- SARS-CoV-2 rS/Matrix M1-Adjuvant
- +2 more
-
Belfast, Antrim, United Kingdom
- +32 more
Oct 19, 2022
Chorea Associated With Huntington Disease Trial in Australia, Canada, United States (SD-809)
Completed
- Chorea Associated With Huntington Disease
-
Birmingham, Alabama
- +37 more
Nov 5, 2021
Multiple Myeloma Trial in Worldwide (Carfilzomib, Dexamethasone)
Completed
- Multiple Myeloma
-
Scottsdale, Arizona
- +139 more
Sep 9, 2022
Non-Cystic Fibrosis Bronchiectasis Trial in Worldwide (Brensocatib 10 mg, Brensocatib 25 mg, Placebo)
Recruiting
- Non-Cystic Fibrosis Bronchiectasis
- Brensocatib 10 mg
- +2 more
-
Birmingham, Alabama
- +416 more
Jan 24, 2023
Influenza, Human Trial in United States (NanoFlu, Fluzone Quadrivalent)
Unknown status
- Influenza, Human
- NanoFlu
- Fluzone Quadrivalent
-
Hollywood, Florida
- +18 more
Apr 16, 2020
Diabetes, Type 1 Trial in Worldwide (insulin icodec, insulin degludec, insulin aspart)
Completed
- Diabetes Mellitus, Type 1
- insulin icodec
- +2 more
-
Concord, California
- +98 more
Feb 2, 2023
Assessment of ASPIRE and HOPE Adherence
Completed
- HIV Prevention
- In-depth Interview (IDIs) or Focus Group Discussion (FGD)
-
Lilongwe, Malawi
- +6 more
Oct 11, 2022
Brain Metastases Trial in Seoul (BT-M01)
Recruiting
- Brain Metastases
- BT-M01
-
Seoul, Song-pa Gu, Korea, Republic ofAsan Medical Center
Oct 6, 2022
Breast Cancer, Metastatic Breast Cancer, Radiation Therapy Complication Trial in Seoul
Recruiting
- Breast Cancer
- +2 more
-
Seoul, Korea, Republic ofSamsung Medical Center
Jun 8, 2023
Parkinson Disease Trial in Seoul, Gyeonggi-do (MRI Imaging)
Not yet recruiting
- Parkinson Disease
- MRI Imaging
-
Seoul, Nowon-gu, Korea, Republic of
- +2 more
Aug 22, 2022
Lennox Gastaut Syndrome (LGS) Trial in Worldwide (Soticlestat, Placebo)
Recruiting
- Lennox Gastaut Syndrome (LGS)
- Soticlestat
- Placebo
-
Phoenix, Arizona
- +109 more
Jan 10, 2023
Chronic Inflammatory Demyelinating Polyradiculoneuropathy Trial in Worldwide (HYQVIA, 0.25% albumin solution with rHuPH20,
Completed
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy
- HYQVIA
- +2 more
-
Phoenix, Arizona
- +82 more
Feb 28, 2022
Locally Recurrent/Metastatic Triple Negative Breast Cancer Trial in United States (radiation, drug, procedure)
Recruiting
- Locally Recurrent/Metastatic Triple Negative Breast Cancer
- external beam radiation therapy
- +2 more
-
Basking Ridge, New Jersey
- +6 more
Aug 8, 2022
Venous Thromboembolism (VTE), Pulmonary Embolism, Deep Vein Thrombosis (DVT) Trial in Worldwide (Edoxaban, Standard of Care)
Completed
- Venous Thromboembolism (VTE)
- +2 more
- Edoxaban
- Standard of Care
-
Tucson, Arizona
- +139 more
Jun 28, 2022
Disease, Hodgkin Trial in Worldwide (brentuximab vedotin, )
Completed
- Disease, Hodgkin
- brentuximab vedotin
- placebo
-
Duarte, California
- +86 more
Apr 22, 2021
Acute Myeloid Leukemia Trial in Tianjin (Mitoxantrone HCl liposome injection, Cytarabine, Homoharringtonine)
Not yet recruiting
- Acute Myeloid Leukemia
- Mitoxantrone hydrochloride liposome injection
- +3 more
-
Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital
Jul 1, 2023